RELATED STUDY
Key Findings:
Type of Study:
Study Result: Inconclusive
Research Location(s):
Year of Pub:
Cannabinoids Studied:
Chemotype:
Terpenes Studied:
Receptors Studied:
Ligands Studied:
DOSING DETAILS 
Study Dosing Objective: Effective Dose
Established Protocol: Effective dose
Route of Administration:
Cannabinoid Ratio: (THC : CBD) 0 : 0 
Dosing Regimen: CBD, THC, or cannabis extracts (5 µg/mL)
Clinical Relevance: All the tested treatments had an anti-inflammatory effect, but their specific effects differed based on the phenotype of the cells and cytokine production. The THC/CBD content may not be the best indicator for anti-inflammatory properties.
Additional Notes: Pharmacokinetic Study Data, Pharmacodynamic Study Data
Citation:
